Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy

Wen Xu(City University of Hong Kong, Shenzhen Research Institute), Annie LM Cheung(City University of Hong Kong, Shenzhen Research Institute)

Oncotarget

December 17, 2014

10.18632/oncotarget.2781

Cited by 70

Related Papers

Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance

|Theranostics|2019|58

Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis

|EBioMedicine|2023|25